Retinopathy of prematurity, a neovascular retinal disorder of childhood, is a leading cause of visual morbidity worldwide. Currently, ROP is treated with anti-VEGF injections and/or retinal laser photocoagulation, both of which are effective but pose potentially difficult long-term outcomes. Some experts agree that better treatment guidelines and increased patient monitoring can make these early therapies even more effective.
Advances in medicine have allowed infants to be born at younger gestational ages, which has consequently fundamentally changed the disease of ROP, according to Darius M.
Uncategorized